Zdrowie i gospodarka · 26/04/2004
FDA Corrects Guidance Document on Changes to Approved Drug Applications
The Food and Drug Administration (FDA) has corrected a notice in the Federal Register due to inadvertent errors in a revised guidance document on changes to approved new drug applications (NDAs) and abbreviated new drug applications (ANDAs).
Source: Federal Register — Food and Drug AdministrationOpen original release →